Navigation Links
European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
Date:11/15/2007

COLUMBIA, Md., Nov. 15 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK) announced today that the Opposition Division of the European Patent Office (EPO) has ruled in favor of Martek and upheld one of the Company's European docosahexaenoic acid (DHA) patents. The modified claims of the patent are narrower than the claims originally granted but broader than the claims that were previously upheld in a December 2000 Opposition Division hearing. The patent, which expires in November 2010, relates to fermentation processes, human and animal food products, pharmaceutical uses of certain claimed microorganisms, and Martek's food DHA production strain.

Fermentation process claims in the patent that provide important commercial protection for Martek were upheld by the EPO, while certain product claims were narrowed by the elimination of coverage for extracted DHA oil. These fermentation process claims are not limited to any particular use of the DHA oil, i.e., they are relevant if the oils from the claimed processes are used in food or nonfood applications, such as human and animal foods, supplements, and pharmaceuticals. The Company believes that, on an overall basis, the patent as modified remains an important part of the Company's intellectual property portfolio and that the narrowing of the claims of the patent should not have any material adverse impact on the Company.

The patent was the subject of a challenge by Aventis Research and Technologies GmbH & Co. KG, and Nagase Limited. The Company believes that it is probable that at least one of the opponents of the patent will appeal the Opposition Division's decision. If an appeal is made, the Appeal Board hearing would be anticipated to oc
'/>"/>

SOURCE Martek Biosciences Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreichs Ataxia by Santhera
2. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
3. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
4. Kline Study: Better Brushing Habits Boost European Oral Care Sales
5. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
6. European Centre for Modern Drug Discovery Established in Hamburg
7. SAFC Expands European Commercial Manufacturing and Storage Capacities With $10 Million Investment
8. Cardica Receives European CE Mark for C-Port Flex A System for Use in Coronary Artery Bypass Surgery
9. Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting
10. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
11. Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkins Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...s push planes to explore their limits, researchers...logy (NIST) are probing the newest microscope tech...the nanoscale. Better nanoscale measurements are c...tion in the semiconductor and nanomanufacturing in...helium ions to generate the signal used to image e...
(Date:9/5/2008)...s only valuable if we possess it in large-sized pi...he case for those interested in exploiting gold,s ...chemical reactions, including the oxidation of poi...ioxide at room temperatures. That process, if indu...eness of catalytic converters that clean automobil...
(Date:9/5/2008)..., Sept. 5 /- Men living in Western,Or...an enlarged prostate,now have the option of out-pa...olitec, Inc. is pleased to announce that a network...breakthrough LIFE(TM) (Laser Induced,Flow Enhancem...ia (BPH),that quickly and gently eliminates swolle...
(Date:9/5/2008)...t. 5 /- Abbott (NYSE: ABT ...tment Conference on Friday,Sept. 12, 2008, in Lon...tions, will make a formal presentation on the comp... A live audio webcast of the presentation will be ... site at http://www.abbottinvestor.com . An,archi...
Breaking Biology Technology:NIST studies how new helium ion microscope measures up 2NIST and partners identify tiny gold clusters as top-notch catalysts 2Revolutionary New In-Office EVOLVE(R) Laser Prostate Treatment Available Throughout Western Oregon 2
...mplementary nanotechnology companies, Imago Scien...British firm. , ,Imago announced Tuesday that it h...nce Ltd. from the UK-based Polaron Plc. The purcha...kes Imago the world,s largest atom probe supplier,...e companies have a great deal in common, including...
...m popularized by columnist Tom Friedman, requires ...ent requires continuous learning and development o... succeed in flat world competition better be creat...o attract and retain the high-caliber talent they ...? It isn,t easy and doesn,t happen overnight. But ...
...ol that might play an important role in rapidly de...piratory illnesses is close to passing a validatio...Hospital and Clinics. , ,The MultiCode panel techn...nces , a Madison biotechnology company, received t...ssor of pediatrics at UW-Madison. Gern, a pediatri...
...either conveniently mobile, nor completely the Int...torage to support a rich Web experience, and mobil...heap enough to support an always-connected browsin...cess to information. So even while we,re frustrate...xperience. , ,This situation is what Seattle-based...
Other Biology Technology:Imago acquires synergistic British firm 2Seven talent management practices that matter 2Seven talent management practices that matter 3Seven talent management practices that matter 4Seven talent management practices that matter 5EraGen diagnostic passes UW tests, could quickly detect bird flu 2EraGen diagnostic passes UW tests, could quickly detect bird flu 3Webaroo aims to make mobile search relevant 2
(Date:9/4/2008)...sts have discovered a gene enhancer, known as HACN...the uniquely opposable human thumb, and possibly a...humans to walk on two legs, according to a paper p...tudy is the first to provide evidence of the exist...witches near genes in the human genome. , Dr. ...
(Date:9/4/2008)...ATINew research from the University of Cincinnati ...ce hard plasticsbisphenol A (BPA)as a risk factor ...n a laboratory study, using fresh human fat tissue...mone, adiponectin, which is responsible for regula...le at a substantially higher risk for metabolic sy...
(Date:9/4/2008)...COLD SPRING HARBOR, N.Y. (Sept. 4, 2008) A varie...nd animalshave biological rhythms, where the timin... is naturally adjusted to allow them to adapt and ...itions. In recent years, significant advances hav...hese rhythms and how they translate into modificat...
(Date:9/4/2008)...tem cell research is the next great leap in medici...y could replace a failing heart, or new cells take...han using stem cells from embryonic sources, which...c issues, scientists have been looking to adult hu...dult stem cells are now being cultivated from vari...
Breaking Biology News(10 mins):Gene enhancer in evolution of human opposable thumb 2Gene enhancer in evolution of human opposable thumb 3Bisphenol A linked to metabolic syndrome in human tissue 2Interdisciplinary volume on biological rhythms serves as both primer and in-depth resource 2Tel Aviv University researchers create new stem cell screening tool 2Researchers disprove long standing belief about HIV treatment 24383 1Researchers disprove long standing belief about HIV treatment 24383 2Researchers disprove long standing belief about HIV treatment 24383 3Plant steroids offer new paradigm for how hormones work 4199 1Plant steroids offer new paradigm for how hormones work 4199 2Plant steroids offer new paradigm for how hormones work 4199 3Jury Award to Englewood Company to Total More Than 241 Million for Breach of Fiduciary Duties in Shareholder Class Action Case 24379 1Jury Award to Englewood Company to Total More Than 241 Million for Breach of Fiduciary Duties in Shareholder Class Action Case 24379 2FDA Grants Pediatric Exclusivity for TOPAMAX 28R 29 Extending the Marketing Exclusivity by Six Months 2708 1FDA Grants Pediatric Exclusivity for TOPAMAX 28R 29 Extending the Marketing Exclusivity by Six Months 2708 2FDA Grants Pediatric Exclusivity for TOPAMAX 28R 29 Extending the Marketing Exclusivity by Six Months 2708 3
...ofessor Mark Pagani in the Department of Geology a...e first detailed history of atmospheric carbon dio...able isotopes of carbon in a National Science Foun...gh the energy we consume, each of us makes a contr...arbon dioxide and methane, in the Earth,s atmosphe...
...tricting calories over decades may add a few years...to live to 125 and beyond, as many have speculated...s that suffering years of misery to remain super-s...f a longer life," said UCLA evolutionary biologist...striction may not make you live forever, but it su...
...ediately notice if the outside world suddenly went...e of our blinks, even though they cause a similar ... So why are we not aware of the frequent mini-blac... discovered that visual sensitivity begins decreas...anisms underlying this process have until now rema...
...ontreal researchers has discovered that GCN2, a pr... information into long-term memory, may be a maste...term memory. Their paper Translational control of ...eIF2a kinase GCN2, which was published in the Augu...first genetic evidence that protein synthesis is c...
Other Biology News:Invasive parasite destroying fish species 2Caloric restriction won't dramatically extend life span in humans: UCLA research 2Caloric restriction won't dramatically extend life span in humans: UCLA research 3Blink, and the brain misses it 2Montreal researchers probe the genetic basis of memory 2
...ses Product Description: ,QIAGEN RNase Inhibitor i...ently and inactivates a variety of ribonucleases (...th RNase T1, T2, H, U1, U2, or CL3. QIAGEN RNase I...ty, whereas HPRI (human placental RNase inhibitor)...
Product Information Request - SuperSignal West Pico COMPLETE Biotinylated Protein Detection Kit from Pierce Biotechnology, Inc.
...igands\n\nReceptor-related research has long been ...labeled ligands selected to keep pace with new dis...cts and services for receptor research and drug di...ligands. If you do not find exactly what you need,...
The Polymerase gene from Thermus aquaticus (strain YT1) is cloned and expressed in E. coli, then highly purified to produce Taq DNA polymerase. It is used in the amplification and sequence testing of
Biology Products: